Pharma and Healthcare News Japan - Japan drug approvals

iPharmaCenter

Putting patients at center

Home
COVID-19 Updates
News
Conferences
Healthcare Policies & Systems
Regional News
Patient info center
Members
Info Zone
More

TGA Approved Zolgensma

Denmark Healthcare System

NICE says OK for Kisqali routine use

All Posts
TraditionalHealthcare
Healthcare Systems
News
Conferences
Know your disease
COVID
Japan drug approvals
USA Pharma News | Healthcare News
Europe Pharma News
Japan drug approvals
Australia Pharma & Healthcare News
Canada Pharma and Healthcare News
Asia | Pharma | Healthcare News

Search

Levima received orphan designation from MHLW |Japan drug approvals | Japan Healthcare System

ipharmaservices

Mar 12

Levima received orphan designation from MHLW |Japan drug approvals | Japan Healthcare System

Expected best selling pharmaceutical products (drugs) in 2021

ipharmaservices

Jan 20

Expected best selling pharmaceutical products (drugs) in 2021

ipharmaservices

Jan 5

Lynparza was approved for three more indications in Japan

Merck’s Keytruda received one more indication and dosage form approval in Japan

ipharmaservices

Aug 25, 2020

Merck’s Keytruda received one more indication and dosage form approval in Japan

ipharmaservices

Jun 2, 2020

Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients

ipharmaservices

May 30, 2020

Astellas received approval for Xtandi in Japan for prostate cancer

AstraZeneca's Lokelma approved in Japan

ipharmaservices

Mar 29, 2020

AstraZeneca's Lokelma approved in Japan

Please donate to support iPharmaCenter. Click on donate button in header to support us. Thank you

Healthcare News

Healthcare System

©2020 by ipharmaservices